Serology testing continues to be an indispensable tool for the management of several disease states, especially for the qualitative determination IgG antibodies to Herpes simplex virus Type 1 (HSV-1) ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

Researchers examined whether exposure to common infectious agents was associated with cognitive performance and risk for mild cognitive impairment or dementia in older adults.

There are eight human herpesviruses (HHVs). Primary infection by any of the eight viruses, usually occurring in childhood, is either asymptomatic or produces fever and rash of skin or mucous membranes ...

Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that ...

A healthy 5-year-old boy came in from playing outside in the evening with the onset of pruritic skin lesions on the left ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced the closing of its previously announced securities purchase ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...